Evidence map›Paper›PMID 30002333›Full record

ReviewMolecules (Basel, Switzerland)2018

Recent Progress in Metal-Based Nanoparticles Mediated Photodynamic Therapy.

Jingyao Sun, Semen Kormakov, Ying Liu, Yao Huang, Daming Wu, Zhaogang Yang

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Metal-based nanoparticle in cancer treatment: lessons learned and challenges.Frontiers in bioengineering and biotechnology · 2024
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. The Role of Optical Imaging in Translational Nanomedicine.Journal of functional biomaterials · 2022
    Review
  13. Review
  14. Review
  15. Article
  16. Influence of Parameters on Photodynamic Therapy of Au@TiONanomaterials (Basel, Switzerland) · 2022
    Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jingyao SunCollege of Mechanical and Electrical Engineering, Beijing University of Chemical Technology, Beijing 100029, China. sunjingyao5566@sina.com.ORCID 0000-0002-0140-0212
Semen KormakovCollege of Mechanical and Electrical Engineering, Beijing University of Chemical Technology, Beijing 100029, China. s_kormakov@bk.ru.ORCID 0000-0003-1628-8793
Ying LiuState Key Laboratory of Organic-Inorganic Composites, Beijing 100029, China. liuying@mail.buct.edu.cn.
Yao HuangCollege of Mechanical and Electrical Engineering, Beijing University of Chemical Technology, Beijing 100029, China. hy06@163.com.
Daming WuCollege of Mechanical and Electrical Engineering, Beijing University of Chemical Technology, Beijing 100029, China. wudaming@vip.163.com.
Zhaogang YangDepartment of Chemical and Biomolecular Engineering, The Ohio State University, Columbus, OH 43210, USA. yang.1140@osu.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Photodynamic therapy (PDT) is able to non-invasively treat and diagnose various cancers and nonmalignant diseases by combining light, oxygen, and photosensitizers (PSs). However, the application of PDT is hindered by poor water solubility and limited light-penetration depth of the currently available photosensitizers (PSs). Water solubility of PSs is crucial for designing pharmaceutical formulation and administration routes. Wavelength of light source at visible range normally has therapeutic depth less than 1 mm. In this review, focus is on the recent research progress of metal-based nanoparticles being applied in PDT. The potential toxicity of these nanoscales and future directions are further discussed.

Indexed as

AnimalsHumansMetal NanoparticlesPhotochemotherapyPhotosensitizing AgentsPhotosensitizing Agentsmetal-based nanoparticlesphotodynamic therapypotential toxicity

Identifiers

PMID30002333
PMCPMC6099795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.